The prestigious Andreas Grüntzig Ethica Award will be presented to Swedish cardiovascular registry experts Lars Wallentin and Stefan James on 22 May 2025 for their groundbreaking contributions in interventional cardiology.
The award recognizes the SWEDEHEART initiative and its interventional subregistry, SCAAR, for advancing patient outcomes through data collection and research.
SWEDEHEART, established in 2009, captures detailed data on cardiovascular patients, emphasizing quality monitoring and promoting transparency for continuous improvement.
SCAAR focuses on coronary interventions with meticulous data collection, enabling trend identification and protocol refinement for optimized patient care.
SWEDEHEART's registry-based trials have revolutionized research by reducing time and costs associated with traditional trials, impacting global studies.
Over 500 scientific publications have stemmed from SWEDEHEART, influencing cardiovascular disease management and treatment guidelines globally.
The Swedish registries' impact extends to promoting healthcare equity by reporting performance metrics and ensuring consistent cardiac care across regions.
SWEDEHEART has inspired similar initiatives worldwide, demonstrating the scalability and impact of registry-based cardiovascular research.
The recognition at EuroPCR 2025 underscores the pivotal role of registries in integrating data science with clinical practice for enhanced patient care.
The award highlights the transformative potential of registry-based research in reshaping the future of interventional cardiology and cardiovascular care.